Reported 2026-10-13Lot BPTB30-100826-199.12% purity · Thymosin Beta-4 - 18.71 mg; BPC-157 - 16.74 mg
Abrir COA
Péptidos liofilizados
BPC-157/TB-500 Blend
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatálogoBPTB-PW
SourceSee lot documentation
FormatPéptidos liofilizados
EstadoAvailable
DisponibilidadEn existencia
Suscríbete cada mes y ahorra 15%$44.20 por entrega. El mismo precio aplica al primer pedido y a las renovaciones.
- Pago como invitado
- Todas las tarjetas
- COA por lote
- Envío en 2 días
- Cancela cuando quieras
BPC-157/TB-500 Blend$52.00COA disponible
01Documentación de loteModelo de COA y registro analítico
02Especificación definidaEl método y el resultado siguen siendo específicos del lote
03Surtido con seguimientoMétodo de envío y asignación de lote confirmados al revisar el pedido
04Uso responsableContexto de laboratorio no clínico
Documentación de lote
Certificado de análisis actual
19 approved certificates are attached to this product record.
Reported 2026-09-17Lot BPTB30-092026-199.12% purity · Thymosin Beta-4 - 16.87 mg, BPC-157 - 15.86 mg
Abrir COA
Reported 2026-06-27Lot BPTB30-072026-199.72% purity · Thymosin Beta-4 - 16.68 mg, BPC-157 - 16.99 mg
Abrir COA
View all historical COAs (16)
Reported 2026-06-27Lot BPTB30-072026-199.72% purity · Thymosin Beta-4 - 16.68 mg, BPC-157 - 16.99 mg
Abrir COA
Reported 2026-05-23Lot BPTB20-052026-499.30% purity · BPC-157 - 11.61 mg, Thymosin Beta-4 - 10.23 mg
Abrir COA
Reported 2026-05-14Lot BPTB20-052026-799.56% purity · BPC-157 – 13.74 mg Thymosin Beta-4 – 13.27 mg
Abrir COA
Reported 2026-04-15Lot BPTB10-042026-199.53% purity · BPC-157 - 6.28 mg, Thymosin Beta-4 - 6.03 mg
Abrir COA
Reported 2026-03-21Lot BPTB20-032026-199.39% purity · BPC-157 – 10.67 mg Thymosin Beta-4 – 9.68 mg
Abrir COA
Reported 2026-03-21Lot BPTB30-01092026-J99.51% purity · BPC-157 – 17.08 mg Thymosin Beta-4 – 17.25 mg
Abrir COA
Reported 2026-02-25Lot BPCTB5-02232026-J99.95% purity · BPC-157 – 6.04 mg Thymosin Beta-4 – 5.48 mg
Abrir COA
Reported 2026-01-15Lot BPTB20-12152025-J99.111% purity · BPC-157 – 12.52 mg, TB-500 – 11.77 mg
Abrir COA
Reported 2026-01-13Lot BPTB30-01092026-199.675% purity · 15mg/15mg
Abrir COA
Reported 2025-12-26Lot BPC1811192025-J99.025% purity · BPC-157–5.81 mg Thymosin Beta-4–4.96 mg
Abrir COA
Reported 2025-12-26Lot BPC1B11192025-J99.222% purity · BPC-157 - 7.12 mg, Thymosin Beta-4 - 5.92 mg
Abrir COA
Reported 2025-11-23Lot BPT81112025-J99.01% purity · 5mg/5mL HPC-157: 6.37 mg TB-500: 6.81 mg
Abrir COA
Reported 2025-10-30Lot BPCTB410242025-0499.23% purity · BPC-157- 6.71 mg Thymosin Beta-4- 6.73 mg
Abrir COA
Reported 2025-10-12Lot BPCTB410082025-0499.44% purity · BPC-157- 5.88 mg Thymosin Beta-4- 5.73 mg
Abrir COA
Reported 2025-08-21Lot BPC1T4608182025-0499.39% purity · BPC-157: 6.93 mg; Thymosin Beta4: 5.05 mg
Abrir COA
Reported 2025-07-18Lot BPCBLEND063025-H98.68% purity · 5mg/5mg
Abrir COA
Información técnica
Record at a glance
- Primary catalog
- Péptidos liofilizados
- Product type
- Variable product
- Disponibilidad
- Available
- Lot control
- Current lot documentation and approved product record control
- Número de catálogo
- BPTB-PW
Contexto de laboratorio previsto
Aplicaciones ilustrativas
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Paquete de documentación
Documentación
- PDFCertificate of Analysis / lot recordMuestra
- PDFProduct data or handling recordMuestra
- PDFSupporting product media archiveMuestra
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
¿Necesitas un registro actual?
Documentación antes de decidir.
Reference BPTB-PW and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
Ver modelo de documentación
